
Sabra Health Care REIT rose 12.5% from $19.08 to $21.47, ahead of the S&P 500's +10.5%. Its worst day was Jun 1 (−4.2%), and its low came Jun 4 at $17.67.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Sabra Health Care REIT shares rose 4.1%, while the S&P 500 fell 1.2%.
+4.1% · S&P 500 −1.2%
EPS of $0.36 beat the $0.25 estimate on $211.9M revenue (est. $200.2M); FY EPS guidance of $1.55–$1.59 against the $1.06 consensus.
Story events cover the past 12 months · Times ET
+1.1% · S&P 500 +0.1%
EPS of $0.39 beat the $0.38 estimate on $221.8M revenue (est. $214.2M); FY EPS guidance of $1.55–$1.59 against the $1.50 consensus.
+1.5% · S&P 500 +1.0%
Sabra Health Care REIT closed at its lowest level of the year, 7.4% below where the year started.
−2.3% · S&P 500 +0.4%
Sabra Health Care REIT closed at its highest level of the year, 17.3% above where the year started.
+0.1% · S&P 500 0.0%
EPS of $0.39 beat the $0.38 estimate on $235.9M revenue (est. $216.7M); FY EPS guidance of $1.53–$1.55 against the $1.50 consensus.
+0.2% · S&P 500 +1.8%
EPS of $0.39 beat the $0.39 estimate on $249.6M revenue (est. $236.1M); FY EPS guidance of $1.54–$1.55 against the $1.52 consensus.
+3.2% · S&P 500 +0.3%
Where it ended: a close of $21.47 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 11, 2027 (EPS est. $0.39, revenue est. $252.4M).
As of the Nov 9, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SBRA and SPY from Benzinga historical bars. Not investment advice.